Aktie • Biotechnologie

Freeline Therapeutics ADR

WKN
A3EEV1
Ticker
FRLN
• 78F0
ISIN
US35655L2060
Marktkapitalisierung
–
Dividendenrendite
–
KGV
–
Gewinn pro Aktie
–
theScreener Rating
–
Nachhaltigkeits-Score
–

Unternehmens­daten

Stammdaten zu Freeline Therapeutics ADR

WKN
A3EEV1
ISIN
US35655L2060
Home-Symbol
FRLN
Symbol
78F0
Branche
Biotechnologie
Sektor
Chemie / Pharma / Gesundheit
Unternehmen
Unbekannt
Land

Marktdaten

Marktkapitalisierung
–
Anzahl Aktien
–
Streubesitz
–

Anteilseigner

Syncona Investment Management Ltd.UBS Securities LLCCHI Advisors LLCJPMorgan Securities LLC (Investment Management)PenderFund Capital Management Ltd.Morgan Stanley Smith Barney LLC (Investment Management)Renaissance Technologies LLCHarbor Capital Advisors, Inc.Sphera Funds Management Ltd.Northern Trust Investments, Inc.(Investment Management)
  • Syncona Investment Management Ltd. (33,65 %)
  • UBS Securities LLC (2,28 %)
  • CHI Advisors LLC (1,99 %)
  • JPMorgan Securities LLC (Investment Management) (1,54 %)
  • PenderFund Capital Management Ltd. (1,39 %)
  • Morgan Stanley Smith Barney LLC (Investment Management) (0,98 %)
  • Renaissance Technologies LLC (0,79 %)
  • Harbor Capital Advisors, Inc. (0,47 %)
  • Sphera Funds Management Ltd. (0,38 %)
  • Northern Trust Investments, Inc.(Investment Management) (0,36 %)

Kontakt